Cetera Advisors LLC Genetic Technologies LTD Call Options Transaction History

Cetera Advisors LLC

  • $0
  • Q1 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

About GENETIC TECHNOLOGIES LTD

GENE Quotes by TradingView
  • Ticker GENE
  • Exchange OTC
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 15,389,900
  • Market Cap $11.9M
  • Description
  • Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...
More about GENE
Track This Portfolio

Track Cetera Advisors LLC Portfolio

Follow Cetera Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email